DiPietro Kenneth
Insider CIK 1540188 · NVIV Director · CERE Chief Human Resources Officer · BIIB EVP Human Resources
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CERE Cerevel Therapeutics Holdi | D To issuer deriv | 2024-08-01 | 2024-08-05 | 63,905 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer deriv | 2024-08-01 | 2024-08-05 | 711,827 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | D To issuer | 2024-08-01 | 2024-08-05 | 25,042 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2024-01-19 | 2024-01-23 | 63,905 | — | $0 | 63,905 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-12-22 | 2023-12-27 | 8,000 | — | $0 | 302,242 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-12-22 | 2023-12-27 | 8,000 | $41.45 | $331.6K | 24,663 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-12-22 | 2023-12-27 | 8,000 | $3.50 | $28.0K | 32,663 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | S Sale | 2023-12-20 | 2023-12-21 | 6,256 | $41.42 | $259.1K | 24,663 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise deriv | 2023-12-19 | 2023-12-21 | 13,913 | — | $0 | 0 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | M Exercise | 2023-12-19 | 2023-12-21 | 13,913 | — | $0 | 30,919 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2023-02-06 | 2023-02-08 | 13,913 | — | $0 | 13,913 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2023-02-06 | 2023-02-08 | 54,749 | — | $0 | 54,749 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2022-02-09 | 2022-02-11 | 75,985 | — | $0 | 75,985 | SEC↗ |
| CERE Cerevel Therapeutics Holdi | A Award deriv | 2021-02-03 | 2021-02-05 | 175,438 | — | $0 | 175,438 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | A Award deriv | 2018-01-19 | 2018-01-23 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2017-02-28 | 2017-03-02 | 1,494 | — | $0 | 5,392 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2017-02-28 | 2017-03-02 | 728 | — | $0 | 1,948 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2017-02-28 | 2017-03-02 | 1,216 | — | $0 | 2,676 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2017-02-28 | 2017-03-02 | 1,198 | — | $0 | 6,886 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2017-02-28 | 2017-03-02 | 1,378 | — | $0 | 1,174 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2017-02-28 | 2017-03-02 | 1 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2017-02-28 | 2017-03-02 | 2,300 | — | $0 | 1 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2017-02-28 | 2017-03-02 | 1,174 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2017-02-28 | 2017-03-02 | 2,300 | — | $0 | 8,260 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2017-02-28 | 2017-03-02 | 1,083 | $274.76 | $297.6K | 7,177 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2017-02-28 | 2017-03-02 | 553 | $274.76 | $151.9K | 5,960 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2017-02-28 | 2017-03-02 | 728 | — | $0 | 4,665 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2017-02-28 | 2017-03-02 | 1,174 | — | $0 | 6,513 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2017-02-28 | 2017-03-02 | 485 | $287.63 | $139.5K | 5,339 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2017-02-28 | 2017-03-02 | 1,494 | — | $0 | 5,824 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2017-02-28 | 2017-03-02 | 335 | $284.75 | $95.4K | 4,330 | SEC↗ |
| BIIB BIOGEN INC. | A Award deriv | 2017-02-15 | 2017-02-17 | 6,380 | — | $0 | 6,380 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | A Award deriv | 2017-01-18 | 2017-01-23 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2016-02-23 | 2016-02-25 | 1,262 | — | $0 | 3,802 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2016-02-23 | 2016-02-25 | 636 | — | $0 | 5,064 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2016-02-23 | 2016-02-25 | 636 | — | $0 | 4,237 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2016-02-23 | 2016-02-25 | 300 | $258.99 | $77.7K | 3,937 | SEC↗ |
| BIIB BIOGEN INC. | A Award deriv | 2016-02-22 | 2016-02-24 | 7,900 | — | $0 | 7,900 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2016-02-12 | 2016-02-17 | 1,070 | — | $0 | 3,912 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2016-02-12 | 2016-02-17 | 2,246 | — | $0 | 2,249 | SEC↗ |
| BIIB BIOGEN INC. | J Other deriv | 2016-02-12 | 2016-02-17 | 1,418 | — | $0 | 2,494 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2016-02-12 | 2016-02-17 | 865 | $247.22 | $213.8K | 3,601 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2016-02-12 | 2016-02-17 | 2,246 | — | $0 | 4,466 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2016-02-12 | 2016-02-17 | 504 | $247.22 | $124.6K | 2,220 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2016-02-12 | 2016-02-17 | 1,070 | — | $0 | 2,724 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2016-02-01 | 2016-02-02 | 2,466 | — | $0 | 1 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2016-02-01 | 2016-02-09 | 2,466 | — | $0 | 1 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2016-02-01 | 2016-02-02 | 812 | $273.45 | $222.0K | 1,654 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2016-02-01 | 2016-02-02 | 2,466 | $273.45 | $674.3K | 2,466 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2016-02-01 | 2016-02-09 | 2,466 | — | $0 | 2,466 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | A Award deriv | 2015-12-10 | 2015-12-11 | 12,500 | — | $0 | 12,500 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | A Award deriv | 2015-07-31 | 2015-08-04 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2015-03-16 | 2015-03-17 | 803 | $415.46 | $333.6K | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award deriv | 2015-02-23 | 2015-02-25 | 5,700 | — | $0 | 5,700 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2015-02-17 | 2015-02-18 | 1,188 | $389.11 | $462.3K | 803 | SEC↗ |
| BIIB BIOGEN IDEC INC. | J Other deriv | 2015-02-12 | 2015-02-17 | 970 | — | $0 | 4,982 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2015-02-12 | 2015-02-17 | 1,518 | — | $0 | 5,952 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2015-02-12 | 2015-02-17 | 2,246 | — | $0 | 4,495 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2015-02-12 | 2015-02-17 | 1,518 | — | $0 | 2,706 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2015-02-12 | 2015-02-17 | 715 | $392.11 | $280.4K | 1,991 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2015-02-12 | 2015-02-17 | 1,058 | $392.11 | $414.9K | 1,188 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2015-02-12 | 2015-02-17 | 2,246 | — | $0 | 2,246 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2015-02-02 | 2015-02-03 | 1,656 | $389.03 | $644.2K | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2015-02-01 | 2015-02-02 | 2,463 | — | $0 | 2,467 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2015-02-01 | 2015-02-02 | 807 | $389.16 | $314.1K | 1,656 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2015-02-01 | 2015-02-02 | 2,463 | — | $0 | 2,463 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | A Award deriv | 2014-12-10 | 2014-12-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-02-13 | 2014-02-14 | 1,290 | $316.81 | $408.7K | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2014-02-12 | 2014-02-14 | 2,246 | — | $0 | 6,741 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award deriv | 2014-02-12 | 2014-02-14 | 7,470 | — | $0 | 7,470 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2014-02-12 | 2014-02-14 | 2,246 | — | $0 | 2,246 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2014-02-12 | 2014-02-14 | 956 | $323.04 | $308.8K | 1,290 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2014-02-04 | 2014-02-05 | 1,655 | $299.01 | $494.9K | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2014-02-01 | 2014-02-03 | 2,463 | — | $0 | 4,930 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2014-02-01 | 2014-02-03 | 808 | $312.64 | $252.6K | 1,655 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2014-02-01 | 2014-02-03 | 2,463 | — | $0 | 2,463 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | A Award deriv | 2013-12-10 | 2013-12-12 | 50,000 | — | $0 | 50,000 | SEC↗ |
| BIIB BIOGEN IDEC INC. | S Sale | 2013-09-30 | 2013-10-02 | 1,440 | $242.00 | $348.5K | 0 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award deriv | 2013-02-12 | 2013-02-14 | 8,987 | — | $0 | 8,987 | SEC↗ |
| BIIB BIOGEN IDEC INC. | J Other deriv | 2013-02-01 | 2013-02-05 | 312 | — | $0 | 7,393 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise deriv | 2013-02-01 | 2013-02-05 | 2,151 | — | $0 | 7,705 | SEC↗ |
| BIIB BIOGEN IDEC INC. | M Exercise | 2013-02-01 | 2013-02-05 | 2,151 | — | $0 | 2,151 | SEC↗ |
| BIIB BIOGEN IDEC INC. | F Tax w/h | 2013-02-01 | 2013-02-05 | 711 | $157.30 | $111.8K | 1,440 | SEC↗ |
| NVIV INVIVO THERAPEUTICS HOLDIN | A Award deriv | 2012-12-18 | 2012-12-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| BIIB BIOGEN IDEC INC. | A Award deriv | 2012-02-01 | 2012-02-03 | 9,856 | — | $0 | 9,856 | SEC↗ |